Reports
Sale
Diabetic Foot Ulcers Market Size, Trends, Analysis, Report: By Product Type: Biologics, Wound Care Dressings; By Type: Neuro-ischemic, Ischemic, Neuropathic, Others; By Route of Administration; Oral, Parenteral, Others; By End User: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy; Regional Analysis; Supplier Landscape; 2024-2032
Diabetic Foot Ulcers Market Outlook
The diabetic foot ulcers market size was valued at USD 6.32 billion in 2023, driven by the rising incidence of diabetes across the 7 major markets. The market is expected to grow at a CAGR of 5.85% during the forecast period of 2024-2032, with the values likely to rise from USD 6.7 billion in 2024 to USD 10.5 billion by 2032.
Diabetic Foot Ulcers: Introduction
Foot ulcers are a common side effect of diabetes when the condition is not being managed well through diet, medication, or exercise. In this condition, the skin tissue breaks down, exposing the layers underneath. It is commonly present under the big toes and balls of the feet. Common symptoms include irritation, swelling, odour, and redness. Partial or complete tissue death may also appear in severe cases. Diabetic foot ulcers are treated with medication like antibiotics or surgical procedures.
Diabetic Foot Ulcers Market Analysis
In the past three decades, the incidence of type 2 diabetes has dramatically increased, affecting 442 million people across the world. The rising prevalence of diabetes is a major factor contributing to the diabetic foot ulcers market demand in recent years.
Diabetes foot ulcer management has a major risk of amputation and structural deformity, therefore, finding novel and effective therapeutics is a key area of attention amongst researchers. Topicals are one of the most used treatment alternatives for the condition. ON101 (Fespixon) is a wound healing cream which has demonstrated promising results in patients. Similarly, topical esmolol 14% hydrochloride, when used in combination with standard care treatment has shown benefits.
Apart from topicals, other medical interventions are also expected to aid the diabetic foot ulcers market growth. In August 2023, researchers at Queen’s University, Belfast used 3D printing technology to develop 3D printed bandages, known as scaffolds, to treat diabetic foot ulcers. This also showcases the increasing application of novel and advanced techniques like 3D printing into the healthcare ecosystem, which is expected to shape the landscape for better patient care in the forecast period.
Diabetic Foot Ulcers Market Segmentation
Market Breakup by Product Type
- Biologics
- Wound Care Dressings
Market Breakup by Type
- Neuro-ischemic
- Ischemic
- Neuropathic
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Others
Market Breakup by End User
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
Diabetic Foot Ulcers Market Overview
During the historical period, the United States led the diabetic foot ulcers market share, which can be largely attributed to increasing medical and research fundings focused on diabetes prevention. In January 2023, a United States senator announced a USD 2.44 billion government funding for developing diabetes associated treatment alternative for patients.
Europe, especially the United Kingdom, is proactive in spreading awareness around diabetes prevention. The Diabetes Prevention Program (NHS DPP) aims to help people across the world with weight loss by encouraging physical activity. In addition, the presence of prominent healthcare companies and research institutions also fuels the market value.
Within Asia Pacific, there is huge emphasis on improving the healthcare infrastructure which is expected to boost the diabetic foot ulcers market value in the region. Having a substantial portion of geriatric population, Japan is developing a diverse set of treatment alternatives for all. The region is also witnessing high mergers and acquisitions for improved patient outcomes.
Diabetic Foot Ulcers Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- ConvaTec, Inc.
- Acelity L.P., Inc
- 3M Healthcare
- Coloplast Corp.
- Smith & Nephew Plc
- B Braun Melsungen AG
- Medline Industries, Inc.
- Organogenesis, Inc.
- Molnlycke Health Care AB
- Medtronics
- Kerecis
- Essity Aktiebolag AB
- Tissue Regenix
- Integra Lifesciences
- Cardinal Health
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetic Foot Ulcers Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetic Foot Ulcers Epidemiology Analysis – 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.1 Germany Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.2 France Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.3 Italy Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.4 Spain Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.4 Japan Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
6 Diabetic Foot Ulcers Market Overview – 7MM
6.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
6.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
7 Diabetic Foot Ulcers Market Landscape – 7MM
7.1 Diabetic Foot Ulcers Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Diabetic Foot Ulcers Product Landscape
7.2.1 Analysis by Products
7.2.2 Analysis by Type
7.2.3 Analysis by Route of Administration
8 Diabetic Foot Ulcers Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Diabetic Foot Ulcers Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Diabetic Foot Ulcers Market Segmentation – 7MM
11.1 Diabetic Foot Ulcers Market by Product Type
11.1.1 Market Overview
11.1.2 Biologics
11.1.3 Wound Care Dressings
11.2 Diabetic Foot Ulcers Market by Type
11.2.1 Market Overview
11.2.2 Neuro-ischemic
11.2.3 Ischemic
11.2.4 Neuropathic
11.2.5 Others
11.3 Diabetic Foot Ulcers Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Parenteral
11.3.4 Others
11.4 Diabetic Foot Ulcers Market by End User
11.4.1 Market Overview
11.4.2 Hospital Pharmacy
11.4.3 Online Pharmacy
11.4.4 Retail Pharmacy
11.5 Diabetic Foot Ulcers Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.5.4 Japan
12 United States Diabetic Foot Ulcers Market
12.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
12.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
12.3 Diabetic Foot Ulcers Market by Disease Type
12.4 Diabetic Foot Ulcers Market by Treatment Type
13 EU-4 and United Kingdom Diabetic Foot Ulcers Market
13.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
13.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
13.3 Germany Diabetic Foot Ulcers Market Overview
13.3.1 Diabetic Foot Ulcers Market by Disease Type
13.3.2 Diabetic Foot Ulcers Market by Treatment Type
13.4 France Diabetic Foot Ulcers Market Overview
13.4.1 Diabetic Foot Ulcers Market by Disease Type
13.4.2 Diabetic Foot Ulcers Market by Treatment Type
13.5 Italy Diabetic Foot Ulcers Market Overview
13.5.1 Diabetic Foot Ulcers Market by Disease Type
13.5.2 Diabetic Foot Ulcers Market by Treatment Type
13.6 Spain Diabetic Foot Ulcers Market Overview
13.6.1 Diabetic Foot Ulcers Market by Disease Type
13.6.2 Diabetic Foot Ulcers Market by Treatment Type
13.7 United Kingdom Diabetic Foot Ulcers Market Overview
13.7.1 Diabetic Foot Ulcers Market by Disease Type
13.7.2 Diabetic Foot Ulcers Market by Treatment Type
14 Japan Diabetic Foot Ulcers Market
14.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
14.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
14.3 Diabetic Foot Ulcers Market by Disease Type
14.4 Diabetic Foot Ulcers Market by Treatment Type
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnership and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 ConvaTec, Inc.
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisition
20.1.5 Certifications
20.2 Acelity L.P., Inc
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisition
20.2.5 Certifications
20.3 3M Healthcare
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisition
20.3.5 Certifications
20.4 Coloplast Corp.
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisition
20.4.5 Certifications
20.5 Smith & Nephew Plc
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisition
20.5.5 Certifications
20.6 B Braun Melsungen AG
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisition
20.6.5 Certifications
20.7 Medline Industries, Inc.
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisition
20.7.5 Certifications
20.8 Organogenesis, Inc.
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisition
20.8.5 Certifications
20.9 Molnlycke Health Care AB
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisition
20.9.5 Certifications
20.10 Medtronics
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisition
20.10.5 Certifications
20.11 Kerecis
20.11.1 Financial Analysis
20.11.2 Product Portfolio
20.11.3 Demographic Reach and Achievements
20.11.4 Mergers and Acquisition
20.11.5 Certifications
20.12 Essity Aktiebolag AB
20.12.1 Financial Analysis
20.12.2 Product Portfolio
20.12.3 Demographic Reach and Achievements
20.12.4 Mergers and Acquisition
20.12.5 Certifications
20.13 Tissue Regenix
20.13.1 Financial Analysis
20.13.2 Product Portfolio
20.13.3 Demographic Reach and Achievements
20.13.4 Mergers and Acquisition
20.13.5 Certifications
20.14 Integra Lifesciences
20.14.1 Financial Analysis
20.14.2 Product Portfolio
20.14.3 Demographic Reach and Achievements
20.14.4 Mergers and Acquisition
20.14.5 Certifications
20.15 Cardinal Health
20.15.1 Financial Analysis
20.15.2 Product Portfolio
20.15.3 Demographic Reach and Achievements
20.15.4 Mergers and Acquisition
20.15.5 Certifications
21 Diabetic Foot Ulcers Market - Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 6.32 billion in 2023, driven by the increasing prevalence of diabetes across the 7 major markets.
The market is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, likely to reach a market value of USD 10.5 billion by 2032.
The market demand is highly driven by the rising advances in topical treatment and increasing approvals for its applications.
The current market trend revolves around the increasing application of new technologies like 3D printing. In August 2023, Belfast based Queen University researchers developed 3D printed bandages, known as scaffolds, to treat diabetic foot ulcers.
Based on product types, the market is divided into biologics and wound care dressings.
Major end users include hospital pharmacies, retail pharmacies, and online pharmacies, among others.
The route of administration can be oral and parenteral, among others.
Based on types, the market is divided into neuro-ischemic, ischemic, neuropathic and others.
The major regions of the market include the United States, Japan, EU-4 and the United Kingdom. EU-4 is segmented into Germany, France, Italy, and Spain.
Key players involved in the market are ConvaTec, Inc., Acelity L.P., Inc., 3M Healthcare, Coloplast Corp., Smith & Nephew Plc, B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Molnlycke Health Care AB, Medtronics, Kerecis, Essity Aktiebolag AB, Tissue Regenix, Integra Lifesciences, and Cardinal Health.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 3299
$2999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 6599
$5999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 8799
$7999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9899
$8999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER